[1]
Pastor-Quirós, L.J. and Correa-Díaz, E.P. 2021. The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective. Global and Regional Health Technology Assessment. 8, 1 (Oct. 2021), 140–146. DOI:https://doi.org/10.33393/grhta.2021.2273.